Vitamin C Drug, Supplement and Food Interactions Guide

Most people think of ascorbic acid as the safest supplement on the shelf, and at ordinary doses it often is. Still, vitamin C interactions do exist. A few are well documented, many are only theoretical, and some affect medical tests rather than the body itself. Knowing which is which can prevent a needless worry or, in rare cases, a real problem.

This guide separates documented interactions from mechanistic speculation, shows how strong the evidence is for each one, and tells you when a conversation with a pharmacist or doctor is worth having. It is a reference for education, not a substitute for professional advice.

Medical disclaimer: This page does not provide individual medical advice. Do not start, stop or change any medicine or supplement because of this article. Talk to your prescriber or pharmacist, who can see your full medication list.

Interaction Summary: What to Know First

• Most healthy adults taking typical doses (under about 500 mg a day) with no regular medicines are unlikely to face meaningful problems.
• Higher doses (1,000 mg or more a day) raise the chance of stomach upset, kidney stone risk in susceptible people, and interference with some lab tests.
• Strongest documented concerns involve iron overload conditions, certain iron-chelation treatment, G6PD deficiency with high-dose intravenous use, and several blood and stool tests.
• Moderate or uncertain concerns include antioxidant combinations with cholesterol-lowering therapy, warfarin, chemotherapy and radiation, and estrogen-containing contraceptives.
• Mostly theoretical concerns involve urine acidification and drug excretion, aluminum absorption and a handful of laboratory findings.

The larger the dose, the more these points matter. Intravenous vitamin C, given in hospitals, reaches blood levels no pill can match and carries its own set of considerations.

How Vitamin C Interactions Are Identified

Not all interaction claims are equal. The way a concern was discovered tells you how much weight to give it.

1. Randomized controlled trials: The most reliable source, but few trials were designed specifically to look for interactions.
2. Pharmacokinetic studies: Small human studies that measure blood levels of a drug with and without ascorbic acid.
3. Case reports and case series: Useful warning signals. They show that something happened, not how often or why.
4. Observational data: Can reveal patterns but are prone to confusion by other factors.
5. Laboratory and animal work: Show what might happen. Many findings in cells do not carry over to people.
6. Chemical and mechanistic reasoning: For example, a vitamin that acidifies urine could, in theory, change how some drugs leave the body.

This page labels each concern as documented, possible or theoretical so you can see where the evidence stands.

Drug Classes of Concern

The table below summarizes broad drug classes where vitamin C and medications may interact, along with the strength of the evidence.

Drug class	Concern	Evidence level
Iron-chelating drugs (deferoxamine)	Higher iron mobilization, possible heart strain in severe iron overload	Documented (case reports, labeling)
Cholesterol therapy (simvastatin plus niacin)	Antioxidant combinations may blunt HDL rise	Documented in one trial; clinical meaning unclear
Warfarin	Possible small drop in anticoagulant effect at high doses	Case reports; weak
Chemotherapy and radiation	Possible effect on treatment activity	Mixed; oncology guidance varies
Estrogen-containing contraceptives	Possible increase in estrogen blood levels at high doses	Small, older study
Thyroid hormone (levothyroxine)	May improve absorption in some patients	Small study
Drugs affected by urine acidity	Altered excretion	Theoretical
Aluminum-containing antacids	Greater aluminum absorption	Theoretical to limited
Dapsone, primaquine and other oxidant drugs (G6PD deficiency)	Risk of hemolysis with high-dose IV use	Documented for IV use
Aspirin	Slightly lower white-blood-cell vitamin levels	Minor, small studies

Specific Documented Interactions: Vitamin C and Medications

Iron-chelation therapy (deferoxamine)

In people with severe iron overload, such as some with thalassemia, ascorbic acid can increase the amount of iron available for chelation. Reports linked large doses to cardiac problems when combined with deferoxamine in people with heavy iron burden. Drug labeling advises caution. Anyone on chelation treatment should take ascorbic acid only under their specialist's direction.

Simvastatin plus niacin and antioxidant combinations

In the HDL-Atherosclerosis Treatment Study, a combination of vitamin E, vitamin C, beta-carotene and selenium appeared to blunt the rise in protective HDL cholesterol produced by simvastatin plus niacin. The trial tested a cocktail rather than vitamin C alone, and the effect on actual heart outcomes is not settled. People on this therapy may want to review antioxidant use with their prescriber.

Warfarin

A 1971 case report described reduced warfarin effect with high-dose ascorbic acid, and later reviews of dietary factors have repeated the concern. Evidence is limited and inconsistent, and ordinary dietary intake is not considered a problem. People on warfarin who start or change a high-dose supplement should tell their anticoagulation clinic so they can monitor INR.

Estrogen-containing contraceptives

A small older study found that 1 gram of ascorbic acid raised blood levels of ethinyl estradiol in women taking oral contraceptives. The clinical importance is unclear, and the finding has not been convincingly confirmed.

Levothyroxine

A small study in people with hypothyroidism and gastritis found that taking ascorbic acid with levothyroxine improved absorption of the thyroid hormone. This is not a reason to self-adjust. Anyone using thyroid medicine should keep timing consistent and let their clinician check blood levels if they change supplements.

Chemotherapy and radiation

Because some cancer treatments work partly through oxidative stress, researchers have questioned whether antioxidant supplements could reduce their effect. A review in a cancer journal found the evidence mixed, with no clear answer. Oncology teams commonly advise discussing every supplement before and during treatment. This applies to oral products and to high-dose IV regimens used in clinics.

G6PD deficiency

Glucose-6-phosphate dehydrogenase deficiency increases the risk of red blood cell breakdown when exposed to oxidant stress. Case reports describe hemolysis after high-dose intravenous ascorbic acid in people with this condition. Screening is commonly done before such infusions. Oral doses at ordinary levels are far less of a concern.

Aspirin

Aspirin can modestly lower vitamin levels in white blood cells and increase urinary loss in small studies. This is generally considered minor, and it does not usually call for a change in treatment.

Theoretical and Mechanistic Interactions

These concerns come from how the compound behaves chemically or in the lab. They are worth knowing about but should not be treated as proven.

• Urine acidification: Very high doses may make urine slightly more acidic. In theory, this could alter the excretion of drugs whose clearance depends on urine pH, such as some stimulants or certain alkaline drugs. Human evidence for meaningful effects at ordinary doses is limited.
• Aluminum absorption: Ascorbic acid can bind aluminum and may increase its uptake. This is mainly a consideration for people with kidney disease who take aluminum-containing medicines.
• Proteasome inhibitors such as bortezomib: Laboratory studies suggest that ascorbic acid might reduce activity of this drug class in cells. Human trials are lacking, and patients should rely on their cancer team's advice.
• Sodium-containing ascorbate: Sodium ascorbate adds sodium. This is a minor point except for people on strict sodium limits.
• Acetaminophen: Early work suggested slight changes in how it is cleared, but no meaningful clinical problem has been shown.

Supplement-Supplement Interactions

• Iron: Ascorbic acid increases the absorption of non-heme iron, including supplement iron. This helps people with low iron but is a concern for those with hemochromatosis or other iron overload conditions.
• Vitamin E: The two nutrients work together in the body, with vitamin C helping regenerate vitamin E. This is not an adverse interaction, though combined antioxidant therapy is the source of the statin-niacin finding above.
• Copper: Some animal studies suggest very high ascorbic acid intake can reduce copper status. Human evidence is limited.
• Vitamin B12: An older claim that large doses destroy B12 was not supported by later work. It is still repeated online and is best regarded as unconfirmed.
• Zinc and AREDS-type formulas: In eye-disease research, vitamin C was used with vitamin E, zinc, copper and other nutrients without a specific vitamin C problem reported.
• Magnesium and other laxative-type minerals: Combined use at high doses may add to loose stools.
• Calcium and mineral ascorbates: Counting the mineral content from ascorbate salts toward the total intake matters for people watching calcium or sodium.

Because supplements often contain several ingredients, check the full label and avoid stacking multiple products that each include ascorbic acid.

Food Interactions and Vitamin C Intake

• Iron-rich plant foods: Vitamin C eaten in the same meal increases non-heme iron absorption from beans, lentils, spinach and fortified cereals. This is a helpful pairing for those prone to low iron.
• Tea and coffee: Polyphenols in these drinks reduce iron absorption. Vitamin C can partly offset this effect.
• Phytates in grains and legumes: These compounds also lower iron absorption, and vitamin C partly counters them.
• Cooking and storage: Heat, long storage and exposure to air reduce the vitamin's content in foods. Steaming briefly or eating produce raw helps preserve it.
• Alcohol and smoking: Both are associated with lower blood levels, which is why smokers are advised to consume more.
• Fruit juice and acidic drinks: Large amounts of citrus products may irritate sensitive stomachs or dental enamel, though this is not a drug interaction.

Food-based vitamin C intake rarely causes meaningful problems. Most interaction concerns involve concentrated supplements.

Vitamin C Lab Test Interference

Vitamin C lab test interference is among the best-documented effects, because the compound is a strong reducing agent that can disturb chemical reactions used in testing.

• Blood glucose meters: Some handheld meters read falsely high or falsely low in the presence of ascorbic acid, depending on the technology used. The effect is most notable with very high levels, such as after IV infusion.
• Urine glucose tests: Certain dipstick methods can give false negatives.
• Stool occult blood tests (guaiac): Ascorbic acid can cause false-negative results, which could mask bleeding. Many instructions advise avoiding high-dose supplements for several days before testing.
• Other chemistry panels: Large amounts can affect some measurements, such as creatinine, uric acid or bilirubin, depending on the method used.

Practical point: If you are scheduled for a blood test, stool test, or use a glucose meter at home, tell the care team or lab about supplements and follow any specific instructions provided.

Severity and Strength of Evidence

Concern	Severity if it occurs	Strength of evidence
Iron overload with extra ascorbic acid or chelation	Potentially serious	Documented
Hemolysis in G6PD deficiency (IV)	Potentially serious	Documented (case reports)
Lab test interference	Moderate (misleading results)	Well documented
Antioxidants and statin-niacin therapy	Unclear	One trial
Warfarin	Potentially moderate	Weak; case reports
Chemotherapy and radiation	Unclear	Mixed
Contraceptive hormone levels	Unclear	Small, older study
Kidney stones at 1,000 mg or more per day	Moderate	Observational, consistent
Urine pH and drug excretion	Unclear	Theoretical
Aluminum absorption	Unclear	Theoretical to limited

How to read this table: Severity describes the potential effect if it happens. Strength of evidence describes how confident researchers are that it happens. Some serious but rare problems have weak evidence. Some well-documented effects, such as test interference, are not harmful on their own but can lead to wrong decisions.

Who Should Consult a Clinician

Talk to a doctor, pharmacist or dietitian before taking more than ordinary food-level or low-dose amounts if you:

• Have hemochromatosis, thalassemia, or take iron-chelating medicine
• Have G6PD deficiency, or are being considered for high-dose IV treatment
• Have kidney disease or a history of kidney stones
• Take warfarin, other anticoagulants, or cholesterol therapy such as statins with niacin
• Are receiving chemotherapy or radiation, or are planning treatment
• Take thyroid hormone, hormonal contraceptives, or medicines with narrow safety margins
• Use home glucose monitoring or are about to have lab tests or colon-cancer screening
• Are pregnant, breastfeeding, or giving supplements to children
• Have an upcoming surgery

Bring your supplement bottles or a photo of the labels. A pharmacist can check for interactions against your full list of medicines.

Frequently Asked Questions

Is it safe to take vitamin C with my regular medications?

For many people at low doses, yes. Because individual circumstances vary, ask a pharmacist to review your list, especially if you take warfarin, thyroid medicine, cholesterol therapy or cancer treatment.

Can vitamin C affect my blood sugar readings?

It can interfere with some glucose meters, especially at high doses. Ask your diabetes care team whether your meter is affected.

Should I stop supplements before a stool test for hidden blood?

Many testing instructions advise avoiding high-dose supplements for a few days beforehand because of the risk of false negatives. Follow the instructions given with your test or ask the lab.

Does it interfere with iron pills?

It generally increases iron absorption. That can be helpful for people with low iron and harmful for people with iron overload, so the question is best answered by your clinician.

Is it safe during cancer treatment?

The evidence is mixed. Tell your oncology team about every supplement you use, and follow their advice.

Do food sources cause the same problems as supplements?

Generally not. Interaction concerns mostly involve concentrated supplement doses.

References

1. NIH Office of Dietary Supplements. Vitamin C: Fact Sheet for Health Professionals.
2. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press; 2000.
3. Brown BG, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583-1592.
4. Nienhuis AW. Vitamin C and iron. N Engl J Med. 1981;304(3):170-171.
5. Hallberg L, Brune M, Rossander L. The role of vitamin C in iron absorption. Int J Vitam Nutr Res Suppl. 1989;30:103-108.
6. Rosenthal G. Interaction of ascorbic acid and warfarin. JAMA. 1971;215(10):1671.
7. Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc. 1995;95(5):580-584.
8. Back DJ, et al. Interaction of ethinyloestradiol with ascorbic acid in man. Br Med J (Clin Res Ed). 1981;282(6276):1516.
9. Jubiz W, Ramirez M. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis. J Clin Endocrinol Metab. 2014;99(12):E1031-E1034.
10. Lawenda BD, et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 2008;100(11):773-783.
11. Tang Z, Du X, Louie RF, Kost GJ. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol. 2000;113(1):75-86.
12. Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med. 1975;83(6):824-826.
13. Thomas LD, et al. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013;173(5):386-388.